Ellen Kapiteijn
0000-0002-4814-6426
Publication & Citation Trends
Publications
475 total
A phantom study to achieve comparable 124I PET recovery and address scanner variability for dosimetry purposes in (re)differentiated thyroid cancer
Cited by 0
Semantic Scholar
Cost-effectiveness of [18F]FDG PET/CT in follow-up after thermal ablation in patients with colorectal liver metastases in the Dutch healthcare setting.
Cited by 0
Semantic Scholar
Metabolic parameters on baseline and early [18F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma
Cited by 2
Semantic Scholar
Arterial inflammation on [18F]FDG PET/CT in melanoma patients treated with and without immune checkpoint inhibitors: CHECK-FLAME I.
Cited by 5
Semantic Scholar
ARTERIAL INFLAMMATION ON [18F]FDG PET/CT IN ADVANCED MELANOMA PATIENTS TREATED WITH AND WITHOUT IMMUNE CHECKPOINT INHIBITOR THERAPY
Cited by 0
Semantic Scholar
Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy.
Cited by 3
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(166)
CAR-T cell therapy research
(162)
Immunotherapy and Immune Responses
(137)
Cutaneous Melanoma Detection and Management
(130)
Melanoma and MAPK Pathways
(110)
Affiliations
Leiden University
Loyola University Medical Center
University of Leeds
Radboud University Nijmegen
B. J. Medical College & Sassoon Hospital